Abstract
PURPOSE OF REVIEW: As novel therapies are expanding the life expectancy of patients with multiple myeloma, appropriate supportive care has become critical in the management of these patients. This review aims to outline the key principles of supportive care of patients with myeloma, including management of bone disease, renal disease, anemia, peripheral neuropathy, infections, and venous thromboembolism.
RECENT FINDINGS: The results from large randomized, controlled trials on the use of high-cutoff hemodialysis in the removal of free light chains in renal disease and the use of levofloxacin in the prevention of infections have recently been published. These results, along with updated guidelines from professional societies on the use of bisphosphonates and erythropoietin stimulating agents, have provided guidance on more effective management strategies for myeloma patients. Integration of these updated guidelines and supportive care strategies into clinical practice will help to ensure quality of life for patients with myeloma.
PMID: 32172361 [PubMed - as supplied by publisher]
14:06
Photo
Not included, change data exporting settings to download.
256×256, 6.0 KB
14:06
In reply to this message
pubmed: caandvteortroorpul
Patient characteristics and long-term outcomes beyond the first 6 months after a diagnosis of cancer-associated venous thromboembolism.
Related Articles
Patient characteristics and long-term outcomes beyond the first 6 months after a diagnosis of cancer-associated venous thromboembolism.
Thromb Res. 2020 Feb 13;188:106-114
Authors: Schmidt RA, Al Zaki A, Desilet N, Szefer E, Ratnaweera N, Peterson E, Lee AYY
No comments:
Post a Comment